Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
UNISEM (M) BERHAD
Code: UNISEM
Current Price: 3.08
MBOW Public Output
Core Conclusion
当前结构处于: 修复阶段后的确认区(偏强震荡,不是主升爆发)
长期大级别仍属于底部修复后的重新站稳过程,周线与日线已从弱势转向中性偏强,但还没有进入像 MPI 那种强趋势主升段。
核心判断:
这票现在不是高位延续, 而是“修复后等待确认突破”的阶段。
真正关键不在上涨本身, 而在能否有效突破 3.15–3.20。
Structure Analysis
月线
月线属于长期底部修复结构。
前期从高位回落后,已经完成深度调整,目前重新回到云层附近。
MACD开始底部修复,Fisher低位回升,说明长期空头压力已经明显减弱。
但注意:
这不是强趋势票, 而是大级别修复票。
周线
周线结构明显改善。
价格重新站回 2.90–3.00关键区域上方,云层支撑开始形成。
MACD周线低位拐头,OBV重新抬升,说明资金开始重新回流。
这是:
防守结束 → 修复确认
但尚未进入:
趋势爆发
日线
日线目前处于最关键位置。
价格连续反弹后来到 3.10附近,正好对应前期重要压力区。
MACD强势金叉,说明短期修复动能很强。
问题在于:
3.10–3.20 是真正的结构门槛。
这里突破, 才会进入下一段。
突破不了, 就容易重新回到箱体震荡。
4H
4H已经进入高位整理。
价格从2.60快速拉升到3.10附近后,MACD高位钝化,柱体缩短,说明短线冲击速度开始下降。
这不是坏事, 这是正常的确认过程。
30分钟
30分钟偏弱震荡。
短线在3.05–3.10来回拉锯,MACD仍在零轴下方修复,OBV恢复有限。
说明:
短线资金仍然谨慎, 没有形成强追价共识。
Multi-Timeframe Rating
Long-Term Rating(月 / 周)
B+
长期修复成立, 但趋势级别仍未完全确认。
Short-Term Rating(日 / 4H / 30m)
B
短线有修复, 但突破确认尚未完成。
Composite Rating(综合结构评级)
B+
属于可持续观察票, 但暂时不是强趋势领涨票。
SPD(速度评分)
6.7 / 10
速度中等偏上, 有动能, 但明显不是爆发型结构。
Key Price Levels
Immediate Resistance
3.12 – 3.20
当前最重要压力区
有效突破后,结构会明显升级
Major Resistance
3.35 – 3.50
中期主要目标区
突破这里才是真正趋势延续
Immediate Support
3.00 – 3.03
第一防守位
守住则维持健康整理
Major Support
2.88 – 2.92
核心结构支撑位
跌破则修复逻辑明显降级
Failure Zone
2.75以下
若失守,说明本轮修复失败
Path A / B / C Scenarios
Path A – 突破确认(45%)
稳住3.00上方
放量突破3.15–3.20
向3.35推进
这是当前主路径, 但确认还没完成
Path B – 区间震荡整理(40%)
持续在2.95–3.15之间反复震荡
等待下一次突破机会
这是非常现实的路径
Path C – 回落失守(15%)
跌破2.90
重新回到弱势箱体
目前概率较低, 但不能忽略
Environment Overlay
Recovery structure remains valid, but confirmation is still required.
Unlike high-momentum leaders, this setup depends heavily on whether price can successfully break the structural ceiling at 3.15–3.20.
Momentum exists, but conviction is not strong enough yet.
This is a stock that rewards patience more than aggression.
Final Verdict
UNISEM 现在不是强攻票, 而是确认票。
结构在变好, 但市场还没有完全承认它。
真正重要的不是“已经涨了多少”, 而是:
突破有没有被确认。
Current Structure State: Recovery Phase With Breakout Confirmation Pending
免责声明: 以上内容仅用于教育与市场结构讨论,不构成任何买卖建议、投资建议或未来走势保证。所有交易决策应自行研究,并自行承担风险。
================================================== ENGLISH VERSION
UNISEM is currently in a recovery phase with breakout confirmation still pending.
The larger structure is improving, but unlike strong momentum leaders, this is not yet a full trend continuation stock. Monthly and weekly charts show that the long-term downside pressure has weakened significantly, and price has successfully reclaimed the important 2.90–3.00 region.
The weekly structure suggests a transition from defense into recovery confirmation. MACD is turning upward from lower levels, and OBV shows funds returning into the stock. However, this is still a repair structure, not a breakout trend structure.
The daily chart is the key battlefield.
Price has rebounded strongly and is now testing the major resistance zone at 3.10–3.20. This area decides whether the stock upgrades into a stronger trend continuation setup or falls back into range-bound consolidation.
The 4H chart shows normal high-level consolidation after the move from 2.60 to above 3.00. Momentum is slowing, but this is not bearish by itself. It is simply the market deciding whether the breakout is real.
The 30-minute chart remains cautious, with weak short-term conviction and sideways price action around 3.05–3.10.
Path A (45%): Hold above 3.00, break 3.15–3.20, and extend toward 3.35.
Path B (40%): Continue sideways consolidation between 2.95 and 3.15 before the next breakout attempt.
Path C (15%): Lose 2.90 and fall back into the weaker trading box.
As long as 3.00 holds, the recovery structure remains valid.
Current Structure State: Recovery Phase With Breakout Confirmation Pending
This analysis is for educational and market-structure discussion only. It is not financial advice, not a buy or sell recommendation, and does not guarantee future price movement. Always do your own research and manage risk accordingly.
Unisem (M) Berhad’s short-term outlook is cautious. Revenue is growing, but profits fell sharply due to margin pressure and higher costs. Management expects a recovery as new Malaysian facilities ramp up, with modest growth guidance ahead. Analysts are mixed: some see upside (RHB target RM 3.04, ~27% gain), but consensus is bearish with average targets around RM 1.73–1.78, implying downside. Key risks include high expenses, weak margins, and trade uncertainties.